Aspirin Effects on Emotional Reactions

Healthy Adults Clinical Trial

Official title:

Effects of Aspirin on Emotional Reactivity, Memory, and Risk-taking

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04146532
• Other study ID #: 2019H0262
• Status: Active, not recruiting
• Phase: Early Phase 1
• Start date: October 8, 2019
• Est. completion date: December 31, 2022

Study information

• Verified date: October 2022
• Source: Ohio State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to determine whether the drug aspirin has effects on emotional reactivity, emotional memory, and risk-taking behaviors.

Description:

The goal of this study is to determine if aspirin (acetylsalicylic acid) alters emotional reactions to emotion evoking pictures as well as memory for them. Using a double-blind parallel arm study, participants will receive either placebo or a pain-relieving dose of aspirin (500mg). One hour later they will complete 30 minutes of tasks. This will include ratings of emotional pictures and memory for them. The paradigm is similar to previous experiments done in this lab using other cyclooxygenase inhibitors: ibuprofen and acetaminophen (Durso, Luttrell, & Way, 2015; Psychological Science, https://doi.org/10.1177/0956797615570366). Risk taking on the Balloon Analogue Risk Task will also be assessed. Participants will be healthy young adult males at Ohio State University.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 270
• Est. completion date: December 31, 2022
• Est. primary completion date: December 31, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

At least 18 years old and biologically male Exclusion Criteria: Due to the use of aspirin in this study, women will be excluded from the study due to potential negative effects it may have on pregnancy

Participants will also be excluded for the following medical reasons:

1. Having an allergy to aspirin, other salicylates, or any other pain reliever/fever reducer.

2. Having or recovering from a viral infection such as the chicken pox or flu.

3. Having taken aspirin or another NSAID drug (aspirin, ibuprofen, naproxen, or others) within the last 8 hours or plan to take aspirin or another NSAID drug in the 8 hours after the end of the study.

4. Having more than three drinks of alcohol in the 8 hours after completion of the study.

5. Having asthma, hay fever, nasal polyps, or chronic respiratory disease.

6. Impaired liver/kidney or impaired cardiovascular circulation (renal vascular disease, congestive heart failure, volume depletion, major surgery, sepsis or major hemorrhagic events)

7. Active or severe liver or kidney disease.

8. An ulcer, history of ulcers or are prone to bleeding.

9. A history of blood clotting defects.

10. Severe anemia.

11. Taking any of the following drugs: A blood thinning anticoagulant (e.g. warfarin), Digoxin, An Angiotensin Converting Enzyme (ACE) Inhibitor, Methotrexate, An oral glucocorticoid (e.g. hydrocortisone),Valproic Acid, A Selective Serotonin Reuptake Inhibitor (SSRI; e.g. Prozac; Zoloft)

12. Have had stomach ulcers or bleeding problems.

13. Have stomach problems such as heartburn, upset stomach, or stomach pain that does not go away or reoccurs.

14. Surgery in the last week or will have a surgery in the next week.

15. High blood pressure.

16. Diabetes, gout, or arthritis.

17. Low uric acid or Glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Related Conditions & MeSH terms

• Healthy Adults

Intervention

Drug:
• Aspirin 500 MG
Single 500mg aspirin capsule.
• Placebo
Single 500mg placebo capsule.

Locations

Country	Name	City	State
United States	Psychology Building	Columbus	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Emotional Reactivity	Changes in self-reported evaluations of valence on a 1 to 7 scale and felt reactions to emotional images on a 1-7 scale.	1.5 hours
Primary	Memory	Changes in memory for emotional pictures. After rating the images, the participants will be shown them again as well as new pictures and asked to indicate whether they have seen the picture before or not.	1.5 hours
Primary	Risk-Taking	We will measure the adjusted average number of pumps on the Balloon Analogue Risk Task.	1.5 hours
Secondary	Individual Differences	Self-reported political ideology will be examined as a moderator of the self-reported ratings of the images as well as memory for them.	1.5 hours